ONCY   $0.95  -2.95% Market Closed After Close 0.97 2.11%

Oncolytics Biotech Inc.
Total Cash 24.85M
totalCashPerShare 0.323
EBITDA -36.45M
Total Debt 1.12M
quickRatio 4.305
currentRatio 4.992
Total Revenue
debtToEquity 6.095
Revenue/Share
ROA -0.71334
ROE -1.38219
grossProfits
freeCashflow -15.77M
operatingCashflow -26.44M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 67.11M
forwardPE -3.733333
floatShares 73.76M
sharesOutstanding 76.86M
sharesShort 2.65M
sharesShortPriorMonth 688.24K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.02%
Short Ratio help_outline 3.57%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 0.238
Price To Book help_outline 4.71
earningsQuarterlyGrowth
netIncomeToCommon -28.02M
trailingEps -0.27%
forwardEps -0.30%
enterpriseToEbitda -1.84
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.07 3Q 2024
institutionsCount 46
lastUpdated Nov. 7, 2024, 2:23 a.m.